{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:07:29Z","timestamp":1792156049407,"version":"4.4.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179566","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T17:38:29Z","timestamp":1498153109000},"page":"e0179566","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-5967","authenticated-orcid":true,"given":"Alessandra","family":"Casonato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Daidone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Galletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bertomoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"issue":"19","key":"ref1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand disease","volume":"302","author":"ZM Ruggeri","year":"1980","journal-title":"N Engl J Med"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2003.00523.x","article-title":"Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works","volume":"2","author":"ZM Ruggeri","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1073\/pnas.82.21.7424","article-title":"Interaction of purified IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb-IIIa complex and initiates aggregation","volume":"82","author":"L De Marco","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653684","article-title":"Ristocetin: a new tool in the investigation of platelet aggregation","volume":"26","author":"MA Howard","year":"1971","journal-title":"Thromb Diath Haemorrh"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood.V41.5.687.687","article-title":"Ristocetin. A means of differentiating von Willebrand's disease into two groups","volume":"41","author":"MA Howard","year":"1973","journal-title":"Blood"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI113095","article-title":"Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors","volume":"80","author":"L De Marco","year":"1987","journal-title":"J Clin Invest"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI115122","article-title":"Molecular basis of von Willebrand disease type IIB: candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences","volume":"87","author":"AM Randi","year":"1991","journal-title":"J Clin Invest"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI115123","article-title":"The molecular defect in type IIB von Willebrand disease: identification of four potential missense mutations within the putative GpIb binding domain","volume":"87","author":"KA Cooney","year":"1991","journal-title":"J Clin Invest"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","article-title":"The complex multimeric composition of Factor VIII\/von Willebrand factor","volume":"57","author":"ZM Ruggeri","year":"1981","journal-title":"Blood"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V55.6.1056.1056","article-title":"Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers","volume":"55","author":"LW Hoyer","year":"1980","journal-title":"Blood"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V58.2.387.387","article-title":"Effect of multimeric structure of the factor VIII\/von Willebrand factor protein on binding platelets","volume":"58","author":"HR Gralnick","year":"1981","journal-title":"Blood"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1538-7836.2007.02296.x","article-title":"Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13","volume":"5","author":"J Rayes","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"AB Federici","year":"2009","journal-title":"Blood"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0609.1990.tb00412.x","article-title":"Platelet aggregation and pseudothrombocytopenia induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient","volume":"45","author":"A Casonato","year":"1990","journal-title":"Eur J Haematol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V69.3.786.786","article-title":"Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand disease","volume":"69","author":"ME Rick","year":"1987","journal-title":"Blood"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00001721-199102000-00005","article-title":"Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease","volume":"2","author":"A Casonato","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.2830330113","article-title":"Postoperative thrombocytopenia in type IIB von Willebrand disease","volume":"33","author":"MB Hultin","year":"1990","journal-title":"Am J Hematol"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIB von Willebrand disease","volume":"309","author":"L Holmberg","year":"1983","journal-title":"N Engl J Med"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647265","article-title":"1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia","volume":"64","author":"A Casonato","year":"1990","journal-title":"Thromb Haemost"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"HJ Weiss","year":"1986","journal-title":"Blood"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"L Holmberg","year":"1993","journal-title":"J Clin Invest"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1182\/blood.V74.6.2028.2028","article-title":"A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction and the presence of all von Willebrand factor multimers in plasma","volume":"74","author":"A Casonato","year":"1989","journal-title":"Blood"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-2143(97)90147-5","article-title":"Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers","volume":"129","author":"A Casonato","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"L Gallinaro","year":"2008","journal-title":"Blood"},{"issue":"33","key":"ref25","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"DJ Mancuso","year":"1989","journal-title":"J Biol Chem"},{"issue":"6","key":"ref26","first-page":"1182","article-title":"A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis","volume":"98","author":"A Casonato","year":"2007","journal-title":"Thromb Haemost"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bjh.13785","article-title":"Higher and lower active circulating VWF levels: different facets of von Willebrand disease","volume":"171","author":"A Casonato","year":"2015","journal-title":"Br J Haematol"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood-2005-03-1153","article-title":"A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS 13 deficiency and von Willebrand disease type 2B","volume":"106","author":"JJ Hulstein","year":"2005","journal-title":"Blood"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.thromres.2009.08.012","article-title":"A family having type 2B von Willebrand disease with an R1306W mutation: severe thrombocytopenia leads to the normalization of high molecular weight multimers","volume":"125","author":"M Ozeki","year":"2010","journal-title":"Thromb Res"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3324\/haematol.2009.019927","article-title":"Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia","volume":"95","author":"A Casonato","year":"2010","journal-title":"Haematologica"},{"issue":"14","key":"ref31","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1182\/blood-2008-06-165233","article-title":"The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation","volume":"113","author":"SC Jackson","year":"2009","journal-title":"Blood"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation","volume":"81","author":"A Casonato","year":"1999","journal-title":"Thromb Haemost"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00001721-199412000-00013","article-title":"Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease","volume":"5","author":"A Casonato","year":"1994","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T23:35:59Z","timestamp":1659137759000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179566"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Garcia de Frutos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179566","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}